NEWS
March 6, 2012 | By Michael A. Memoli
Rep. Donald Payne, the first African American elected to Congress from New Jersey and the dean of that state's delegation, died Tuesday after a long battle with colon cancer. He was 77. Payne represented New Jersey's heavily democratic 10th District, encompassing parts of Union, Hudson and Essex counties, including sections of Newark. He was a teacher, business executive and local officeholder before winning his seat in Congress in 1988. He was easily reelected 11 more times. Payne was chairman of the Congressional Black Caucus Foundation and had held several leadership roles in the House.
BUSINESS
January 10, 2012 | By David Lazarus
Here's your take-me-home-tonight Tuesday roundup of consumer news from around the Web: -- There's no sugar high for Hostess Brands, maker of the Twinkie and other fine products. The company is reportedly preparing to go back into bankruptcy just two years after completing its last bankruptcy proceedings. People familiar with the matter say the company is facing a cash crunch with more than $860 million in debt, high labor expenses and rising ingredient costs. When Hostess, then called Interstate Bakeries, filed for bankruptcy protection in 2004, it blamed low sales and high fixed costs.
NEWS
October 27, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
Patients with a genetic condition that increases their risk of colon and other cancers who took aspirin daily developed colon cancer less often than patients who took a placebo, researchers reported Thursday. The study, which was the first randomized controlled trial to look at the effect of aspirin on cancer rates, was published in the journal the Lancet. Professor John Burn, a geneticist at Newcastle University in England, led the research team. The group followed 861 people with Lynch syndrome, which increases the risk of developing colon and other cancers. Some of the patients took two 600 mg aspirins every day, others took a placebo.
NEWS
October 12, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
Ginger root supplements may help tamp down markers for colon inflammation, a study finds. The study, published online Tuesday in the journal Cancer Prevention Research , included 30 men and women who were randomly assigned to take 2 grams of a ginger root supplement or a placebo for 28 days. The participants were at normal risk for colon cancer -- they had no family history of the disease and no evidence of the disease. Ginger root is a popular supplement that's often used to treat stomach ailments.
NEWS
September 27, 2011 | By Eryn Brown, Los Angeles Times / for the Booster Shots blog
In England, getting screened and treated for colorectal cancer -- the second leading cause of cancer death in the United Kingdom and worldwide -- is free. So why do only about half of thepopulation go through with it? The answer, suggests a new study in the journal Cancer Epidemiology, Biomarkers and Prevention, is something of a self-fulfilling prophecy:people believe if they're going to get cancer, they'll die from it anyway, so why bother? This attitude, known as cancer fatalism, is known to be a factor in African Americans' lower rates of colorectal cancer screening in the U.S. It may also be a key reason people of lower socioeconomic status in the U.K. fail to follow through on testing, reported University of London Psychologist Anne Miles and colleagues.
NEWS
August 1, 2011 | By Rosie Mestel, Los Angeles Times / For the Booster Shots blog
Colon cleansing? Seriously, why would anyone go get their guts irrigated out if they didn't have to do it, say, as prep for a colonoscopy? OK, so I'm not a stellar housekeeper. I first read of the practice back in the early 1990s in an article by Cecil Adams , who answers readers' questions in his "The Straight Dope" column, and it made an impression. "We're talking about a high-tech enema here," Cecil wrote as part of his detailed -- too detailed -- response to a question about the practice.